下肢动脉硬化闭塞症腔内治疗进展_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 陈忠 , 杨耀国

首都医科大学附属北京安贞医院血管外科，首都医科大学血管外科学系（北京 100053）;

Corresponding author：

陈忠, Email: chenzhong8658@vip.sina.com

Keywords：

DOI：

10.7507/1007-9424.201712104

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 陈忠, 杨耀国. 下肢动脉硬化闭塞症腔内治疗进展. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2018, 25(1): 3-9. doi: 10.7507/1007-9424.201712104 Copy

1.	中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南. 中华医学杂志, 2015, 95(24): 1883-1896.
2.	Bolia A, Miles KA, Brennan J, et al. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol, 1990, 13(6): 357-363.
3.	冯志刚. 下肢动脉硬化闭塞症患者采用内膜下血管成形术治疗的临床效果分析. 血管与腔内血管外科杂志, 2015, 11(1): 140-142.
4.	吴泽涛, 李焕祥, 马彦寿, 等. 内膜下血管成形术治疗慢性下肢长段动脉硬化闭塞症的疗效分析. 青海医药杂志, 2015, 45(1): 56-58.
5.	蒋米尔. 内膜下血管成形术治疗下肢动脉硬化闭塞症. 中国实用外科杂志, 2008, 28(10): 837-839.
6.	刘暴, 刘昌伟, 吴巍巍, 等. 内膜下技术治疗髂动脉闭塞性疾病. 中国医学科学院学报, 2007, 29(1): 44-46.
7.	Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol, 2008, 31(4): 687-697.
8.	李祥祥, 陆信武, 叶开创, 等. 内膜下血管成形术治疗下肢动脉慢性闭塞性病变的荟萃分析. 中华医学杂志, 2012, 92(21): 1486-1491.
9.	符伟国, 唐骁, 郭大乔. 下肢动脉闭塞性病变治疗术中重返真腔的常用器械及其注意事项. 中国血管外科杂志 (电子版), 2013, 5(4): 206-208.
10.	张宏鹏, 郭伟, 刘小平, 等. 股浅动脉闭塞性病变中 Outback LTD 导管的应用分析. 中华外科杂志, 2012, 50(3): 226-229.
11.	李贝贝, 畅智慧, 马羽佳, 等. Outback 导管辅助内膜下成形术治疗下肢动脉硬化闭塞症的文献系统评价. 中华放射学杂志, 2015, 49(2): 143-145.
12.	Ramjas G, Thurley P, Habib S. The use of a re-entry catheter in recanalization of chronic inflow occlusions of the common iliac artery. Cardiovasc Intervent Radiol, 2008, 31(3): 650-654.
13.	Gandini R, Fabiano S, Spano S, et al. Randomized control study of the outback LTD reentry catheter versus manual reentry for the treatment of chronic total occlusions in the superficial femoral artery. Catheter Cardiovasc Interv, 2013, 82(3): 485-492.
14.	Noory E, Rastan A, Schwarzwälder U, et al. Retrograde transpopliteal recanalization of chronic superficial femoral artery occlusion after failed re-entry during antegrade subintimal angioplasty. J Endovasc Ther, 2009, 16(5): 619-623.
15.	杨淼, 张童, 石波, 等. 远端动脉逆行穿刺治疗复杂下肢动脉闭塞性病变的初步体会. 中华放射学杂志, 2012, 46(8): 735-737.
16.	Saito S. Different strategies of retrograde approach in coronary angioplasty for chronic total occlusion. Catheter Cardiovasc Interv, 2008, 71(1): 8-19.
17.	王炜, 刘长建, 乔彤. 透视引导下远端动脉逆行开通技术在下肢动脉慢性闭塞性疾病中的应用. 介入放射学杂志, 2015, 24(2): 110-113.
18.	谷涌泉, 郭连瑞, 郭建明, 等. 经腓动脉穿刺双球囊技术开通股浅动脉全程闭塞导致的严重下肢缺血 1 例报告. 中国微创外科杂志, 2014, 20(1): 84-85.
19.	张学强, 时秀华, 李成恩, 等. 逆行突破技术在股-腘动脉闭塞症腔内治疗中的应用. 医学影像学杂志, 2016, 26(9): 1690-1693.
20.	史伟浩, 余波, 何勍, 等. 仰卧体位下经腘动脉逆行入路治疗股浅动脉慢性完全闭塞. 中国临床医学, 2013, 20(3): 287-288.
21.	包俊敏. 下肢动脉闭塞腔内治疗策略的新思考. 中国血管外科杂志 (电子版), 2017, 9(2): 81-83.
22.	Patlola R, Hebert C, Allie D. Orbital atherectomy in treatment of peripheral arterial occlusive disease below the knee a large singl ecenter experience[J]. Am J Cardiol, 2009, 104(6): 24D-25D.
23.	Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther, 2006, 13(5): 592-602.
24.	熊江, 郭伟, 贾鑫, 等. 血管斑块切除系统治疗股浅动脉病变 (2 例报告). 军医进修学院学报, 2010, 31(1): 97-98.
25.	孙利坤, 王兵, 刘俊超, 等. SilverHawk 斑块切除系统在股腘动脉硬化闭塞性疾病中的应用. 实用医学杂志, 2017, 33(18): 3060-3063.
26.	谷涌泉, 郭连瑞, 齐立行, 等. TurboHawk 斑块切除治疗伴严重钙化斑块的下肢动脉硬化闭塞症 2 例. 中国微创外科杂志, 2016, 16(5): 449-451.
27.	Brodmann M, Rief P, Froehlich H, et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovasc Intervent Radiol, 2013, 36(1): 69-74.
28.	庄俊丽, 姚野, 李敬博, 等. 经皮机械血栓旋切术在下肢血管疾病中的临床分析. 国际外科学杂志, 2015, 42(12): 845-848.
29.	Norgren L, Hiatt WR, Dormandy JA, et al. Inter—society consernsus for the management of peripheral arterial disease(TASC II) [J]. J Vasc Surg, 2007, 45 suppl S: S5-S67.
30.	Köksoy C, Yilmaz MF, Başbuğ HS, et al. Pharmacomechanical thrombolysis of symptomatic acute and subacute deep vein thrombosis with a rotational thrombectomy device. J Vasc Interv Radiol, 2014, 25(12): 1895-1900.
31.	Suri R, Wholey MH, Postoak D, et al. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv, 2006, 67(3): 417-422.
32.	李宏伟, 罗宇东, 范海伦, 等. 经皮机械血栓清除术治疗下肢动脉狭窄伴血栓形成病变的近期疗效观察. 天津医科大学学报, 2017, 23(5): 430-433, 441.
33.	Bajorek B, Lemay KS, Magin P, et al. Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges. Pharm Pract (Granada), 2016, 14(2): 723.
34.	Schiffrin EL, Campbell NR, Feldman RD, et al. Hypertension in Canada: Past, Present, and Future. Ann Glob Health, 2016, 82(2): 288-299.
35.	Kubaska SM, Greenberg RK. Techniques for the percutaneous treatment of acute arterial occlusion. Semin Vasc Surg, 2001, 14(2): 114-122.
36.	张雷, 陆清声, 裴轶飞, 等. AngioJet 机械血栓抽吸技术在动脉栓塞及血栓形成中的应用体会. 中国血管外科杂志 (电子版), 2016, (03): 203-207.
37.	Minko P, Katoh M, Jaeger S, et al. Atherectomy of heavily calcified femoropopliteal stenotic lesions. J Vasc Interv Radiol, 2011, 22(7): 995-1000.
38.	Lichtenberg M, Käunicke M, Hailer B. Rotational thrombectomy as treatment option for acute and subacute occluded femoropopliteal bypasses[J]. Zeitschrifl fur Gefassmedizin, 2011, 8(4): 5-10.
39.	Dippel EJ, Makam P, Kovach R, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv, 2015, 8(1 Pt A): 92-101.
40.	Serino F, Cao Y, Renzi C, et al. Excimer laser ablation in the treatment of total chronic obstructions in critical limb ischaemia in diabetic patients. Sustained efficacy of plaque recanalisation in mid-term results. Eur J Vasc Endovasc Surg, 2010, 39(2): 234-238.
41.	杨熙园, 沈雅平, 龙吉甫, 等. 下肢动脉硬化闭塞症的介入治疗现状及其研究进展. 中华临床医师杂志 (电子版). 2016, 10:18-21.
42.	孙利坤, 王兵. 药物涂层球囊在下肢动脉硬化闭塞性疾病中的应用进展. 实用医学杂志, 2017, 33(14): 2415-2418.
43.	Sarode K, Spelber DA, Bhatt DL, et al. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease. JACC Cardiovasc Interv, 2014, 7(8): 827-839.
44.	Speck U, Stolzenburg N, Peters D, et al. How does a drug-coated balloon work? Overview of coating techniques and their impact. J Cardiovasc Surg (Torino), 2016, 57(1): 3-11.
45.	滕树恩, 黄铮, 洪承路, 等. 药物涂层球囊与药物洗脱支架治疗支架内再狭窄的 Meta 分析. 实用医学杂志, 2015, (20): 3408-3411.
46.	Tepe G, Schnorr B, Albrecht T, et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv, 2015, 8(1 Pt A): 102-108.
47.	Tepe G, Laird J, Schneider P, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation, 2015, 131(5): 495-502.
48.	Kayssi A, Al-Atassi T, Oreopoulos G, et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Database Syst Rev, 2016, (8): CD011319.
49.	Rosenfield K, Jaff MR, White CJ, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med, 2015, 373(2): 145-153.
50.	陈旭姣, 刘兆玉. 药物涂层球囊在股腘动脉硬化性病变中的应用进展. 中国介入影像与治疗学, 2017, 14(9): 576-579.
51.	Gandini R, Del Giudice C, Merolla S, et al. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther, 2013, 20(6): 805-814.
52.	Sixt S, Carpio Cancino OG, Treszl A, et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg, 2013, 58(3): 682-686.
53.	Liistro F, Grotti S, Porto I, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv, 2013, 6(12): 1295-1302.
54.	Ott I, Cassese S, Groha P, et al. Randomized comparison of paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation, 2017, 135(23): 2218-2226.
55.	王爱林, 徐恒, 刘军, 等. 切割球囊扩张在股浅动脉长段闭塞治疗中的作用. 中国介入心脏病学杂志, 2012, 20(3): 156-158.
56.	Hayes DJ Jr, Dougherty MJ, Calligaro KD. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting. Ann Vasc Surg, 2011, 25(4): 559.e19-e23.
57.	王吉昌, 禄韶英. 下肢动脉慢性完全闭塞病变的开通导丝选择及治疗策略. 中华老年多器官疾病杂志, 2017, 16(10): 797-800.
58.	Ko YG, Kim JS, Choi DH, et al. Improved technical success and midterm patency with subintimal angioplasty compared to intraluminal angioplasty in long femoropopliteal occlusions. J Endovasc Ther, 2007, 14(3): 374-381.
59.	Kawasaki D, Iida O, Fukunaga M, et al. Wire Passages of 0.035-inch Looped Wire Technique for Femoropopliteal Long Total Occlusions. J Atheroscler Thromb, 2015, 22(10): 1071-1079.
60.	Tóth GG, Yamane M, Heyndrickx GR. How to select a guidewire: technical features and key characteristics. Heart, 2015, 101(8): 645-652.
61.	Baert SA, van Walsum T, Niessen WJ. Endpoint localization in guide wire tracking during endovascular interventions. Acad Radiol, 2003, 10(12): 1424-1432.
62.	顾建平, 楼文胜, 徐克. 加强下肢动脉硬化闭塞症介入治疗的研究. 介入放射学杂志, 2011, 20(10): 757-759.
63.	Aboyans V, Ricco JB, Bartelink ML, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc, available online 26 August 2017. https://doi.org/10.1016/j.ejvs.2017.07.018.
64.	庄金满, 李选. 下肢动脉硬化闭塞症的治疗进展. 中国微创外科杂志, 2014, 14(9): 839-843.
65.	Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation, 2007, 115(21): 2745-2749.
66.	Schneider JR, Verta MJ, Alonzo MJ, et al. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease. Vasc Endovascular Surg, 2011, 45(5): 391-397.
67.	Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention, 2014, 10(7): 861-868.

1. 中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南. 中华医学杂志, 2015, 95(24): 1883-1896.
2. Bolia A, Miles KA, Brennan J, et al. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol, 1990, 13(6): 357-363.
3. 冯志刚. 下肢动脉硬化闭塞症患者采用内膜下血管成形术治疗的临床效果分析. 血管与腔内血管外科杂志, 2015, 11(1): 140-142.
4. 吴泽涛, 李焕祥, 马彦寿, 等. 内膜下血管成形术治疗慢性下肢长段动脉硬化闭塞症的疗效分析. 青海医药杂志, 2015, 45(1): 56-58.
5. 蒋米尔. 内膜下血管成形术治疗下肢动脉硬化闭塞症. 中国实用外科杂志, 2008, 28(10): 837-839.
6. 刘暴, 刘昌伟, 吴巍巍, 等. 内膜下技术治疗髂动脉闭塞性疾病. 中国医学科学院学报, 2007, 29(1): 44-46.
7. Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol, 2008, 31(4): 687-697.
8. 李祥祥, 陆信武, 叶开创, 等. 内膜下血管成形术治疗下肢动脉慢性闭塞性病变的荟萃分析. 中华医学杂志, 2012, 92(21): 1486-1491.
9. 符伟国, 唐骁, 郭大乔. 下肢动脉闭塞性病变治疗术中重返真腔的常用器械及其注意事项. 中国血管外科杂志 (电子版), 2013, 5(4): 206-208.
10. 张宏鹏, 郭伟, 刘小平, 等. 股浅动脉闭塞性病变中 Outback LTD 导管的应用分析. 中华外科杂志, 2012, 50(3): 226-229.
11. 李贝贝, 畅智慧, 马羽佳, 等. Outback 导管辅助内膜下成形术治疗下肢动脉硬化闭塞症的文献系统评价. 中华放射学杂志, 2015, 49(2): 143-145.
12. Ramjas G, Thurley P, Habib S. The use of a re-entry catheter in recanalization of chronic inflow occlusions of the common iliac artery. Cardiovasc Intervent Radiol, 2008, 31(3): 650-654.
13. Gandini R, Fabiano S, Spano S, et al. Randomized control study of the outback LTD reentry catheter versus manual reentry for the treatment of chronic total occlusions in the superficial femoral artery. Catheter Cardiovasc Interv, 2013, 82(3): 485-492.
14. Noory E, Rastan A, Schwarzwälder U, et al. Retrograde transpopliteal recanalization of chronic superficial femoral artery occlusion after failed re-entry during antegrade subintimal angioplasty. J Endovasc Ther, 2009, 16(5): 619-623.
15. 杨淼, 张童, 石波, 等. 远端动脉逆行穿刺治疗复杂下肢动脉闭塞性病变的初步体会. 中华放射学杂志, 2012, 46(8): 735-737.
16. Saito S. Different strategies of retrograde approach in coronary angioplasty for chronic total occlusion. Catheter Cardiovasc Interv, 2008, 71(1): 8-19.
17. 王炜, 刘长建, 乔彤. 透视引导下远端动脉逆行开通技术在下肢动脉慢性闭塞性疾病中的应用. 介入放射学杂志, 2015, 24(2): 110-113.
18. 谷涌泉, 郭连瑞, 郭建明, 等. 经腓动脉穿刺双球囊技术开通股浅动脉全程闭塞导致的严重下肢缺血 1 例报告. 中国微创外科杂志, 2014, 20(1): 84-85.
19. 张学强, 时秀华, 李成恩, 等. 逆行突破技术在股-腘动脉闭塞症腔内治疗中的应用. 医学影像学杂志, 2016, 26(9): 1690-1693.
20. 史伟浩, 余波, 何勍, 等. 仰卧体位下经腘动脉逆行入路治疗股浅动脉慢性完全闭塞. 中国临床医学, 2013, 20(3): 287-288.
21. 包俊敏. 下肢动脉闭塞腔内治疗策略的新思考. 中国血管外科杂志 (电子版), 2017, 9(2): 81-83.
22. Patlola R, Hebert C, Allie D. Orbital atherectomy in treatment of peripheral arterial occlusive disease below the knee a large singl ecenter experience[J]. Am J Cardiol, 2009, 104(6): 24D-25D.
23. Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther, 2006, 13(5): 592-602.
24. 熊江, 郭伟, 贾鑫, 等. 血管斑块切除系统治疗股浅动脉病变 (2 例报告). 军医进修学院学报, 2010, 31(1): 97-98.
25. 孙利坤, 王兵, 刘俊超, 等. SilverHawk 斑块切除系统在股腘动脉硬化闭塞性疾病中的应用. 实用医学杂志, 2017, 33(18): 3060-3063.
26. 谷涌泉, 郭连瑞, 齐立行, 等. TurboHawk 斑块切除治疗伴严重钙化斑块的下肢动脉硬化闭塞症 2 例. 中国微创外科杂志, 2016, 16(5): 449-451.
27. Brodmann M, Rief P, Froehlich H, et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovasc Intervent Radiol, 2013, 36(1): 69-74.
28. 庄俊丽, 姚野, 李敬博, 等. 经皮机械血栓旋切术在下肢血管疾病中的临床分析. 国际外科学杂志, 2015, 42(12): 845-848.
29. Norgren L, Hiatt WR, Dormandy JA, et al. Inter—society consernsus for the management of peripheral arterial disease(TASC II) [J]. J Vasc Surg, 2007, 45 suppl S: S5-S67.
30. Köksoy C, Yilmaz MF, Başbuğ HS, et al. Pharmacomechanical thrombolysis of symptomatic acute and subacute deep vein thrombosis with a rotational thrombectomy device. J Vasc Interv Radiol, 2014, 25(12): 1895-1900.
31. Suri R, Wholey MH, Postoak D, et al. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv, 2006, 67(3): 417-422.
32. 李宏伟, 罗宇东, 范海伦, 等. 经皮机械血栓清除术治疗下肢动脉狭窄伴血栓形成病变的近期疗效观察. 天津医科大学学报, 2017, 23(5): 430-433, 441.
33. Bajorek B, Lemay KS, Magin P, et al. Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges. Pharm Pract (Granada), 2016, 14(2): 723.
34. Schiffrin EL, Campbell NR, Feldman RD, et al. Hypertension in Canada: Past, Present, and Future. Ann Glob Health, 2016, 82(2): 288-299.
35. Kubaska SM, Greenberg RK. Techniques for the percutaneous treatment of acute arterial occlusion. Semin Vasc Surg, 2001, 14(2): 114-122.
36. 张雷, 陆清声, 裴轶飞, 等. AngioJet 机械血栓抽吸技术在动脉栓塞及血栓形成中的应用体会. 中国血管外科杂志 (电子版), 2016, (03): 203-207.
37. Minko P, Katoh M, Jaeger S, et al. Atherectomy of heavily calcified femoropopliteal stenotic lesions. J Vasc Interv Radiol, 2011, 22(7): 995-1000.
38. Lichtenberg M, Käunicke M, Hailer B. Rotational thrombectomy as treatment option for acute and subacute occluded femoropopliteal bypasses[J]. Zeitschrifl fur Gefassmedizin, 2011, 8(4): 5-10.
39. Dippel EJ, Makam P, Kovach R, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv, 2015, 8(1 Pt A): 92-101.
40. Serino F, Cao Y, Renzi C, et al. Excimer laser ablation in the treatment of total chronic obstructions in critical limb ischaemia in diabetic patients. Sustained efficacy of plaque recanalisation in mid-term results. Eur J Vasc Endovasc Surg, 2010, 39(2): 234-238.
41. 杨熙园, 沈雅平, 龙吉甫, 等. 下肢动脉硬化闭塞症的介入治疗现状及其研究进展. 中华临床医师杂志 (电子版). 2016, 10:18-21.
42. 孙利坤, 王兵. 药物涂层球囊在下肢动脉硬化闭塞性疾病中的应用进展. 实用医学杂志, 2017, 33(14): 2415-2418.
43. Sarode K, Spelber DA, Bhatt DL, et al. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease. JACC Cardiovasc Interv, 2014, 7(8): 827-839.
44. Speck U, Stolzenburg N, Peters D, et al. How does a drug-coated balloon work? Overview of coating techniques and their impact. J Cardiovasc Surg (Torino), 2016, 57(1): 3-11.
45. 滕树恩, 黄铮, 洪承路, 等. 药物涂层球囊与药物洗脱支架治疗支架内再狭窄的 Meta 分析. 实用医学杂志, 2015, (20): 3408-3411.
46. Tepe G, Schnorr B, Albrecht T, et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv, 2015, 8(1 Pt A): 102-108.
47. Tepe G, Laird J, Schneider P, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation, 2015, 131(5): 495-502.
48. Kayssi A, Al-Atassi T, Oreopoulos G, et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Database Syst Rev, 2016, (8): CD011319.
49. Rosenfield K, Jaff MR, White CJ, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med, 2015, 373(2): 145-153.
50. 陈旭姣, 刘兆玉. 药物涂层球囊在股腘动脉硬化性病变中的应用进展. 中国介入影像与治疗学, 2017, 14(9): 576-579.
51. Gandini R, Del Giudice C, Merolla S, et al. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther, 2013, 20(6): 805-814.
52. Sixt S, Carpio Cancino OG, Treszl A, et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg, 2013, 58(3): 682-686.
53. Liistro F, Grotti S, Porto I, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv, 2013, 6(12): 1295-1302.
54. Ott I, Cassese S, Groha P, et al. Randomized comparison of paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation, 2017, 135(23): 2218-2226.
55. 王爱林, 徐恒, 刘军, 等. 切割球囊扩张在股浅动脉长段闭塞治疗中的作用. 中国介入心脏病学杂志, 2012, 20(3): 156-158.
56. Hayes DJ Jr, Dougherty MJ, Calligaro KD. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting. Ann Vasc Surg, 2011, 25(4): 559.e19-e23.
57. 王吉昌, 禄韶英. 下肢动脉慢性完全闭塞病变的开通导丝选择及治疗策略. 中华老年多器官疾病杂志, 2017, 16(10): 797-800.
58. Ko YG, Kim JS, Choi DH, et al. Improved technical success and midterm patency with subintimal angioplasty compared to intraluminal angioplasty in long femoropopliteal occlusions. J Endovasc Ther, 2007, 14(3): 374-381.
59. Kawasaki D, Iida O, Fukunaga M, et al. Wire Passages of 0.035-inch Looped Wire Technique for Femoropopliteal Long Total Occlusions. J Atheroscler Thromb, 2015, 22(10): 1071-1079.
60. Tóth GG, Yamane M, Heyndrickx GR. How to select a guidewire: technical features and key characteristics. Heart, 2015, 101(8): 645-652.
61. Baert SA, van Walsum T, Niessen WJ. Endpoint localization in guide wire tracking during endovascular interventions. Acad Radiol, 2003, 10(12): 1424-1432.
62. 顾建平, 楼文胜, 徐克. 加强下肢动脉硬化闭塞症介入治疗的研究. 介入放射学杂志, 2011, 20(10): 757-759.
63. Aboyans V, Ricco JB, Bartelink ML, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc, available online 26 August 2017. https://doi.org/10.1016/j.ejvs.2017.07.018.
64. 庄金满, 李选. 下肢动脉硬化闭塞症的治疗进展. 中国微创外科杂志, 2014, 14(9): 839-843.
65. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation, 2007, 115(21): 2745-2749.
66. Schneider JR, Verta MJ, Alonzo MJ, et al. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease. Vasc Endovascular Surg, 2011, 45(5): 391-397.
67. Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention, 2014, 10(7): 861-868.

Previous Article
胸腔镜纵隔手术中超声刀的规范及强化应用
Next Article
原发性肝癌诊疗规范（2017 年版）解读

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

下肢动脉硬化闭塞症腔内治疗进展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content